Western Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Western Wealth Management's BIIB Position: Q3 2026 in Review
Western Wealth Management reduced its Biogen (BIIB) stake by 3.8% in Q3 2026, selling an estimated $8.7K and leaving 1,047 shares worth $237K. The position accounts for 0.01% of the portfolio, ranked #868.
Western Wealth Management first reported a position in BIIB in Q4 2018 and has held it in 26 quarters since. The position peaked at $988K in Q1 2022. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Western Wealth Management held 1,047 shares of Biogen worth $237K as of Q3 2026.
- Western Wealth Management sold 41 Biogen shares in Q3 2026, an estimated $8.7K.
- Biogen made up 0.01% of Western Wealth Management's portfolio in Q3 2026, its #868 holding.
- Western Wealth Management first reported a position in Biogen in Q4 2018 and has held it in 26 quarters since.
- Western Wealth Management's Biogen position peaked at $988K in Q1 2022.
- 1,062 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Western Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.